1. New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic Strategies
   Yuanyuan Zhao et al, 2022, Genes CrossRef
2. DNA methylation in cardiac fibrosis: New advances and perspectives
   Hui Tao et al, 2014, Toxicology CrossRef
3. MicroRNAs and cardiac fibrosis: A comprehensive update on mechanisms and consequences
   Zekihan Gocer et al, 2023, Pathology - Research and Practice CrossRef
4. Persistent phenotypic shift in cardiac fibroblasts: impact of transient renin angiotensin system inhibition
   Taben M. Hale, 2016, Journal of Molecular and Cellular Cardiology CrossRef
5. Rno_circRNA_008646 regulates formaldehyde induced lung injury through Rno-miR-224 mediated FOXI1/CFTR axis
   Yan-Qi Yang et al, 2022, Ecotoxicology and Environmental Safety CrossRef
6. Regulation of podoplanin expression by microRNA-29b associates with its antiapoptotic effect in angiotensin II-induced injury of human podocytes
   Andreas Eisenreich et al, 2016, Journal of Hypertension CrossRef
7. Persistent change in cardiac fibroblast physiology after transient ACE inhibition
   K. M. D'Souza et al, 2015, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
8. MicroRNA-224: as a potential target for miR-based therapy of cancer
   Wei Chen et al, 2015, Tumor Biology CrossRef
9. MicroRNA‑219 overexpression serves a protective role during liver fibrosis by targeting tumor growth factor β receptor 2
   Li Ma et al, 2018, Molecular Medicine Reports CrossRef
10. Cardiac fibroblast‐specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin‐6 signaling mechanism
    Sumia A. Bageghni et al, 2018, The FASEB Journal CrossRef
11. Retracted: Downregulated microRNA‐224 aggravates vulnerable atherosclerotic plaques and vascular remodeling in acute coronary syndrome through activation of the TGF‐β/Smad pathway
    Hai‐Ming Xu et al, 2019, Journal of Cellular Physiology CrossRef
12. Epigenetic Modifications in Fibrotic Diseases: Implications for Pathogenesis and Pharmacological Targets
    Hong-Wei Yao et al, 2015, Journal of Pharmacology and Experimental Therapeutics CrossRef
13. MicroRNA-21 Mediates Angiotensin II-Induced Liver Fibrosis by Activating NLRP3 Inflammasome/IL-1β Axis via Targeting Smad7 and Spry1
    Zuo-Wei Ning et al, 2017, Antioxidants & Redox Signaling CrossRef
14. ACE-Triggered Hypertension Incites Stroke: Genetic, Molecular, and Therapeutic Aspects
    Kanika Vasudeva et al, 2020, NeuroMolecular Medicine CrossRef